Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
CANbridge Pharmaceuticalscanbridgepharma.com · Low evidenceCanbridge is a global biopharmaceutical company founded in 2012 that develops and delivers therapies for rare diseases and rare oncology, leveraging its China foundation. The company's pipeline includes gene therapies, and its products include Hunterase ERT and Livmarli IBAT inhibitor.
Parse Score